{"DataElement":{"publicId":"4633431","version":"1","preferredName":"Administration Route Name","preferredDefinition":"An established means of access for administration of agents.","longName":"2012668v3.0:4632531v1.0","context":"ONC SDC Project","contextVersion":"1","DataElementConcept":{"publicId":"2012668","version":"3","preferredName":"Access Route","preferredDefinition":"An established means of access (for administration of agents, taking vital signs, etc.).","longName":"ACCESS_RTE","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2635254","version":"1","preferredName":"Access","preferredDefinition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","longName":"C25396","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Access","conceptCode":"C25396","definition":"The right to obtain or make use of or take advantage of something (as services or membership); the right to enter.  Also, an act or means of approaching.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F6F5266-4618-4643-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-05-01","modifiedBy":"ONEDATA","dateModified":"2007-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2452898","version":"1","preferredName":"Route","preferredDefinition":"A method of achieving something. (from Cambridge Advanced Learner's Dictionary - online)","longName":"C25169","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Route","conceptCode":"C25169","definition":"A way of getting from one place to another; an established line of travel or access; the way a chemical or pollutant enters an organism after contact, particularly, the way of drug administration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-6BC1-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"ONEDATA","dateModified":"2006-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A56E8150-8ED5-1CC3-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"REEVESD","dateModified":"2016-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4632531","version":"1","preferredName":"Route Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"4632531v1.0","context":"ONC SDC Project","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Vaginal","valueDescription":"Vaginal Route of Administration","ValueMeaning":{"publicId":"2659979","version":"1","preferredName":"Vaginal Route of Administration","longName":"2659979","preferredDefinition":"Administration of a drug into the vagina. The medication usually has the form of a solution, tablet, cream, gel, or suppository. The drug is slowly absorbed through the vaginal wall with predominantly local, but some systemic effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Route of Administration","conceptCode":"C38313","definition":"Administration of a drug into the vagina. The medication usually has the form of a solution, tablet, cream, gel, or suppository. The drug is slowly absorbed through the vaginal wall with predominantly local, but some systemic effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-DA45-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"DWARZEL","dateModified":"2016-05-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D3D9-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Urethral","valueDescription":"Intraurethral Route of Administration","ValueMeaning":{"publicId":"2577935","version":"1","preferredName":"Intraurethral Route of Administration","longName":"2577935","preferredDefinition":"Administration of a drug directly into the urethra.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraurethral Route of Administration","conceptCode":"C38271","definition":"Administration of a drug directly into the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D3E4-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown Route of Administration","ValueMeaning":{"publicId":"4633411","version":"1","preferredName":"Unknown Route of Administration","longName":"4633411","preferredDefinition":"The route of drug administration is unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown Route of Administration","conceptCode":"C38311","definition":"The route of drug administration is unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D3EF-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D408-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Transplacental","valueDescription":"Transplacental Route of Administration","ValueMeaning":{"publicId":"2581013","version":"1","preferredName":"Transplacental Route of Administration","longName":"2581013","preferredDefinition":"Administration of a drug to an embryo in utero via systemic administration of the substance to the pregnant mother. Drugs cross the placenta through passive diffusion, active transport, pinocytosis and filtration. The properties of drugs that determine placental transfer by passive diffusion include molecular weight, pKa, lipid solubility and protein binding. Drugs with molecular weight of over 500 D are transferred incompletely. Drug metabolism and uptake can be altered by placental enzymes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transplacental Route of Administration","conceptCode":"C38307","definition":"Administration of a drug to an embryo in utero via systemic administration of the substance to the pregnant mother. Drugs cross the placenta through passive diffusion, active transport, pinocytosis and filtration. The properties of drugs that determine placental transfer by passive diffusion include molecular weight, pKa, lipid solubility and protein binding. Drugs with molecular weight of over 500 D are transferred incompletely. Drug metabolism and uptake can be altered by placental enzymes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0982-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D41C-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Transmammary","valueDescription":"Transmammary Route of Administration","ValueMeaning":{"publicId":"4633413","version":"1","preferredName":"Transmammary Route of Administration","longName":"4633413","preferredDefinition":"Administration by ingestion of colostrum or breast milk.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transmammary Route of Administration","conceptCode":"C111326","definition":"Administration into the body through colostrum or milk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D42A-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D443-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Transdermal","valueDescription":"Transdermal Route of Administration","ValueMeaning":{"publicId":"2581012","version":"1","preferredName":"Transdermal Route of Administration","longName":"2581012","preferredDefinition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transdermal Route of Administration","conceptCode":"C38305","definition":"Administration of a substance through the dermal layer of the skin into the systemic circulation by diffusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0981-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D44D-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Topical","valueDescription":"Topical Route of Administration","ValueMeaning":{"publicId":"2577941","version":"1","preferredName":"Topical Route of Administration","longName":"2577941","preferredDefinition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Topical Route of Administration","conceptCode":"C38304","definition":"The application of a drug to a certain area of the skin or mucous membrane (including the intra-organ application), or other tissue locally, so that the agent will take effect on the surface and/or on the underlying tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD82-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D458-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Sublingual","valueDescription":"Sublingual Route of Administration","ValueMeaning":{"publicId":"2577977","version":"1","preferredName":"Sublingual Route of Administration","longName":"2577977","preferredDefinition":"Administration beneath the tongue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sublingual Route of Administration","conceptCode":"C38300","definition":"Administration of a drug beneath the tongue. The route provides rapid absorption, the drug immediately enters the bloodstream without first passing through the intestinal wall and liver. However, most drugs cannot be taken this way because they may be absorbed incompletely or erratically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D46D-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Subcutaneous","valueDescription":"Subcutaneous Route of Administration","ValueMeaning":{"publicId":"2578038","version":"1","preferredName":"Subcutaneous Route of Administration","longName":"2578038","preferredDefinition":"Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subcutaneous Route of Administration","conceptCode":"C38299","definition":"Drug administration beneath the skin. It provides for relatively slow, sustained release of the drug. The rate of absorption into the blood is perfusion-limited, proportional to the amount of drug at the site and can be enhanced by chemical or physical stimulation of blood flow. Subcutaneous administration minimizes the risks associated with intravascular injection: for subcutaneous infusions, external and implantable pumps are used.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D482-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Subconjunctival","valueDescription":"Subconjunctival Route of Administration","ValueMeaning":{"publicId":"2578013","version":"1","preferredName":"Subconjunctival Route of Administration","longName":"2578013","preferredDefinition":"Administration beneath the conjunctiva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subconjunctival Route of Administration","conceptCode":"C38298","definition":"The introduction of a substance beneath the conjunctiva.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDCA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D497-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Retrobulbar","valueDescription":"Retrobulbar Route of Administration","ValueMeaning":{"publicId":"2578010","version":"1","preferredName":"Retrobulbar Route of Administration","longName":"2578010","preferredDefinition":"Administration behind the pons or behind the eyeball.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retrobulbar Route of Administration","conceptCode":"C38296","definition":"The introduction of a substance behind the pons or behind the eyeball.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D4AC-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Respiratory (Inhalation)","valueDescription":"Inhalation Route of Administration","ValueMeaning":{"publicId":"2577932","version":"1","preferredName":"Inhalation Route of Administration","longName":"2577932","preferredDefinition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inhalation Route of Administration","conceptCode":"C38216","definition":"Administration of a substance in the form of a gas, aerosol, or fine powder via the respiratory tract, usually by oral or nasal inhalation, for local or systemic effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD79-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D4C1-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Rectal","valueDescription":"Rectal Route of Administration","ValueMeaning":{"publicId":"2581011","version":"1","preferredName":"Rectal Route of Administration","longName":"2581011","preferredDefinition":"The introduction of a substance into the gastrointestinal tract by the way of the rectum, usually for systemic action. Depending on the molecular structure, drugs cross the rectal wall via either intercellular or tight junctions interconnecting the mucosal cells. Drug absorption is usually around 50% of normal oral dose. Due to the drainage pattern of the rectal veins, the hepatic first-pass effect tends to increase as the dosage form is placed deeper into the rectum. Solid suppositories represent greater than 98% of all rectal dosage forms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Route of Administration","conceptCode":"C38295","definition":"The introduction of a substance into the gastrointestinal tract by the way of the rectum, usually for systemic action. Depending on the molecular structure, drugs cross the rectal wall via either intercellular or tight junctions interconnecting the mucosal cells. Drug absorption is usually around 50% of normal oral dose. Due to the drainage pattern of the rectal veins, the hepatic first-pass effect tends to increase as the dosage form is placed deeper into the rectum. Solid suppositories represent greater than 98% of all rectal dosage forms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0980-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D4D6-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Perineural","valueDescription":"Perineural Route of Administration","ValueMeaning":{"publicId":"2578039","version":"1","preferredName":"Perineural Route of Administration","longName":"2578039","preferredDefinition":"Administration surrounding a nerve or nerves.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Perineural Route of Administration","conceptCode":"C38293","definition":"Administration of a substance within the tissues surrounding a nerve or nerves.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D4EB-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Periarticular","valueDescription":"Periarticular Route of Administration","ValueMeaning":{"publicId":"2578041","version":"1","preferredName":"Periarticular Route of Administration","longName":"2578041","preferredDefinition":"Administration around a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Periarticular Route of Administration","conceptCode":"C38292","definition":"Administration of a substance within the tissues surrounding a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D500-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Parenteral","valueDescription":"Parenteral Route of Administration","ValueMeaning":{"publicId":"2581010","version":"1","preferredName":"Parenteral Route of Administration","longName":"2581010","preferredDefinition":"Administration of a substance by some other means than through the gastrointestinal tract: usually through injection, infusion, or implantation. Predominantly, the drug action is systemic, but in some cases, it is confined to local area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parenteral Route of Administration","conceptCode":"C38291","definition":"Administration of a substance by some means other than through the gastrointestinal tract: usually through injection, infusion, or implantation. Predominantly, the drug action is systemic, but in some cases, it is confined to local area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-097F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D515-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Route of Administration","ValueMeaning":{"publicId":"3698078","version":"1","preferredName":"Other Route of Administration","longName":"3698078","preferredDefinition":"Route of drug administration not specified on this list.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Route of Administration","conceptCode":"C38290","definition":"Route of drug administration not specified on this list.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7F87591-0676-A535-E040-BB89AD437E5F","latestVersionIndicator":"Yes","beginDate":"2013-03-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D520-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Oropharyngeal","valueDescription":"Oropharyngeal Route of Administration","ValueMeaning":{"publicId":"2577976","version":"1","preferredName":"Oropharyngeal Route of Administration","longName":"2577976","preferredDefinition":"Administration directly to the mouth and pharynx..","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal Route of Administration","conceptCode":"C38289","definition":"Administration of a drug directly to the mouth and pharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D534-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Oral","valueDescription":"Oral Route of Administration","ValueMeaning":{"publicId":"2581009","version":"1","preferredName":"Oral Route of Administration","longName":"2581009","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-097E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D53F-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Ophthalmic","valueDescription":"Ophthalmic Route of Administration","ValueMeaning":{"publicId":"2577938","version":"1","preferredName":"Ophthalmic Route of Administration","longName":"2577938","preferredDefinition":"Administration of a drug to the external eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ophthalmic Route of Administration","conceptCode":"C38287","definition":"Administration of a drug to the external surfaces of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D553-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Occlusive Dressing Technique","valueDescription":"Occlusive Dressing Technique","ValueMeaning":{"publicId":"2578007","version":"1","preferredName":"Occlusive Dressing Technique","longName":"2578007","preferredDefinition":"Administration by the topical route which is then covered by a dressing which occludes the area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occlusive Dressing Technique","conceptCode":"C38286","definition":"Administration of a substance by the topical route that is then covered by a dressing which occludes the area of drug application.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D568-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Iontophoresis","valueDescription":"Iontophoresis Route of Administration","ValueMeaning":{"publicId":"2581007","version":"1","preferredName":"Iontophoresis Route of Administration","longName":"2581007","preferredDefinition":"Ion transfer of topical solution into the epidermis and mucous membranes of body by continuous direct current. Can be used for local and systemic drug delivery. Concept does not refer to ion exchange, air ionization, and phonophoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iontophoresis Route of Administration","conceptCode":"C38203","definition":"Ion transfer of topical solution into the epidermis and mucous membranes of body by continuous direct current. Can be used for local and systemic drug delivery. Concept does not refer to ion exchange, air ionization, and phonophoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-097C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D57D-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intravesical","valueDescription":"Intravesical Route of Administration","ValueMeaning":{"publicId":"2577982","version":"1","preferredName":"Intravesical Route of Administration","longName":"2577982","preferredDefinition":"Administration within the bladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravesical Route of Administration","conceptCode":"C38278","definition":"The administration of a drug within the urinary bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D588-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intravenous Not Otherwise Specified","valueDescription":"Intravenous","ValueMeaning":{"publicId":"4633414","version":"1","preferredName":"Intravenous","longName":"4633414","preferredDefinition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous","conceptCode":"C13346","definition":"Into or within a vein. Intravenous usually refers to a way of giving a drug or other substance through a needle or tube inserted into a vein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D593-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D5AC-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intravenous Drip","valueDescription":"Intravenous Drip","ValueMeaning":{"publicId":"2578036","version":"1","preferredName":"Intravenous Drip","longName":"2578036","preferredDefinition":"Administration within or into a vein or veins over a sustained period of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Drip","conceptCode":"C38279","definition":"The administration of a drug within or into a vein or veins over a sustained period of time. A slow, continuous drip avoids excessively high transient peak plasma levels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D5C0-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intravenous Bolus","valueDescription":"Intravenous Bolus","ValueMeaning":{"publicId":"2581084","version":"1","preferredName":"Intravenous Bolus","longName":"2581084","preferredDefinition":"Administration of a drug directly into circulation via a vein or veins over a time duration of less than or equal to 30 minutes. Method results in 100% bioavailability of the agent due to an absence of the absorption phase. FDA CDER (HL7) numeric code: 0138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intravenous Bolus","conceptCode":"C38274","definition":"A volume of drug intended to be administered into a vein at a relatively fast rate. The volume of drug and the rate of administration are specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-09C9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-08","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-08-08","modifiedBy":"REEVESD","dateModified":"2011-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D5D5-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intratracheal","valueDescription":"Endotracheal Route of Administration","ValueMeaning":{"publicId":"2577075","version":"1","preferredName":"Endotracheal Route of Administration","longName":"2577075","preferredDefinition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endotracheal Route of Administration","conceptCode":"C38208","definition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D5EA-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intrathoracic","valueDescription":"Endothoracic Route of Administration","ValueMeaning":{"publicId":"2578049","version":"1","preferredName":"Endothoracic Route of Administration","longName":"2578049","preferredDefinition":"Administration of a drug within the thorax (internal to the ribs).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endothoracic Route of Administration","conceptCode":"C38207","definition":"Administration of a drug within the thorax (internal to the ribs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDEE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D5FE-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intrathecal","valueDescription":"Intrathecal Space","ValueMeaning":{"publicId":"4633416","version":"1","preferredName":"Intrathecal Space","longName":"4633416","preferredDefinition":"Describes the fluid-filled space between the thin layers of tissue that cover the brain and spinal cord. Drugs can be injected into the fluid or a sample of the fluid can be removed for testing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrathecal Space","conceptCode":"C12943","definition":"The fluid-filled space between the thin layers of tissue that cover the brain and spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D60C-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D625-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intratumor","valueDescription":"Intratumoral Route of Administration","ValueMeaning":{"publicId":"2578029","version":"1","preferredName":"Intratumoral Route of Administration","longName":"2578029","preferredDefinition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral Route of Administration","conceptCode":"C38269","definition":"The administration of a drug within or introduced directly into a tumor. Method allows to achieve high concentration of the agent in the tumor and delay drug release in systemic circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDDA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D639-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intrasynovial","valueDescription":"Intrasynovial Route of Administration","ValueMeaning":{"publicId":"2578048","version":"1","preferredName":"Intrasynovial Route of Administration","longName":"2578048","preferredDefinition":"Administration within the synovial cavity of a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrasynovial Route of Administration","conceptCode":"C38264","definition":"The administration of a drug within the synovial cavity of a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDED-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D64E-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intrapleural","valueDescription":"Intrapleural Route of Administration","ValueMeaning":{"publicId":"2578021","version":"1","preferredName":"Intrapleural Route of Administration","longName":"2578021","preferredDefinition":"Administration within the pleura.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrapleural Route of Administration","conceptCode":"C38259","definition":"Administration of a drug within the pleural cavity. The intrapleural drug administration usually results in both local and systemic drug action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D663-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intraperitoneal","valueDescription":"Intraperitoneal Route of Administration","ValueMeaning":{"publicId":"2578020","version":"1","preferredName":"Intraperitoneal Route of Administration","longName":"2578020","preferredDefinition":"Administration within the peritoneal cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraperitoneal Route of Administration","conceptCode":"C38258","definition":"Administration of a drug via injection or infusion of a substance into the peritoneum, where it is absorbed by the lining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D66E-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intrapericardial","valueDescription":"Intrapericardial Route of Administration","ValueMeaning":{"publicId":"2578019","version":"1","preferredName":"Intrapericardial Route of Administration","longName":"2578019","preferredDefinition":"Administration within the pericardium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrapericardial Route of Administration","conceptCode":"C38257","definition":"Administration of a drug within the pericardium. Intrapericardial application of therapeutic agents provides a strategy for site-specific treatment of heart or coronary diseases. The magnitude of the local advantage depends on substance exchange between the local and the blood compartments and on substance elimination from these compartments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDD0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D682-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intraocular","valueDescription":"Intraocular Route of Administration","ValueMeaning":{"publicId":"2578011","version":"1","preferredName":"Intraocular Route of Administration","longName":"2578011","preferredDefinition":"Administration within the eye.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraocular Route of Administration","conceptCode":"C38255","definition":"Administration of a drug within the eye. Intraocular drugs are almost always used for their local effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A42DC54-D697-6CA0-E050-BB89AD431B37","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"ONEDATA","dateModified":"2014-12-15","deletedIndicator":"No"},{"value":"Intramuscular","valueDescription":"Intramuscular Route of Administration","ValueMeaning":{"publicId":"2578009","version":"1","preferredName":"Intramuscular Route of Administration","longName":"2578009","preferredDefinition":"Administration within a muscle.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramuscular Route of Administration","conceptCode":"C28161","definition":"Intramuscular injection is a route of drug administration via injection into muscle tissue. Aqueous or oleaginous solutions and emulsions or suspensions may be administered. Absorption rates, delay in availability of the drug to the systemic circulation, and duration of effect are perfusion-limited, depend on molecular size of the agent, volume, and osmolarity of the drug solution, fat content of the injection site, and patient physical activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B046-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intrameningeal","valueDescription":"Intrameningeal Route of Administration","ValueMeaning":{"publicId":"2578006","version":"1","preferredName":"Intrameningeal Route of Administration","longName":"2578006","preferredDefinition":"Administration within the meninges (the three membranes that envelope the brain and spinal cord).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrameningeal Route of Administration","conceptCode":"C38254","definition":"The administration of a drug within meningeal membranes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B05B-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intramedullary","valueDescription":"Intramedullary Route of Administration","ValueMeaning":{"publicId":"2578018","version":"1","preferredName":"Intramedullary Route of Administration","longName":"2578018","preferredDefinition":"Administration within the marrow cavity of a bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intramedullary Route of Administration","conceptCode":"C38253","definition":"Administration of a drug within the marrow cavity of a bone. The essential premise for intraosseous administration is a functioning medullary cavity. The route is considered reasonably safe and permits rapid achievement of satisfactory plasma concentrations of therapeutic agent. The route is used for blood transfusion or fluid therapy when other routes are awkward, as in neonates.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDCF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B066-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intralymphatic","valueDescription":"Intralymphatic Route of Administration","ValueMeaning":{"publicId":"2578031","version":"1","preferredName":"Intralymphatic Route of Administration","longName":"2578031","preferredDefinition":"Administration within the lymph.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intralymphatic Route of Administration","conceptCode":"C38252","definition":"Administration of a drug within the lymphatic system: into the lymph nodes or/and the lymph vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDDC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B07B-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intralesional","valueDescription":"Intralesional Route of Administration","ValueMeaning":{"publicId":"2578032","version":"1","preferredName":"Intralesional Route of Administration","longName":"2578032","preferredDefinition":"Administration within or introduced directly into a localized lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intralesional Route of Administration","conceptCode":"C38250","definition":"Administration of a drug within or introduced directly into a localized lesion. Method allows to achieve high concentration of the agent in the lesion and delay drug release in systemic circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDDD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B090-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intrahepatic","valueDescription":"Intrahepatic Route of Administration","ValueMeaning":{"publicId":"3629942","version":"1","preferredName":"Intrahepatic Route of Administration","longName":"3629942","preferredDefinition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Route of Administration","conceptCode":"C38248","definition":"Intrahepatic route of drug administration is a method of drug delivery within the liver, predominantly via hepatic vein or artery. Regimen might be more beneficial then systemic one by delivering a higher dose of drug to the liver and reducing overall systemic exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CF057A49-845F-F346-E040-BB89AD432CDD","latestVersionIndicator":"Yes","beginDate":"2012-11-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-11-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B09B-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intradiscal","valueDescription":"Intradiscal Route of Administration","ValueMeaning":{"publicId":"2578004","version":"1","preferredName":"Intradiscal Route of Administration","longName":"2578004","preferredDefinition":"Administration within a disc.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intradiscal Route of Administration","conceptCode":"C38239","definition":"Administration of a drug within a fibrocartilaginous intervertebral disc.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDC1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B0B0-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intradermal","valueDescription":"Intradermal Route of Administration","ValueMeaning":{"publicId":"2578084","version":"1","preferredName":"Intradermal Route of Administration","longName":"2578084","preferredDefinition":"Administration within the dermis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intradermal Route of Administration","conceptCode":"C38238","definition":"Intradermal injection is a method of drug administration within the substance of the skin, particularly the dermis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE11-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-03-01","modifiedBy":"ONEDATA","dateModified":"2006-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B0C5-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracoronary","valueDescription":"Intracoronary Route of Administration","ValueMeaning":{"publicId":"2578052","version":"1","preferredName":"Intracoronary Route of Administration","longName":"2578052","preferredDefinition":"Administration within the coronary arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracoronary Route of Administration","conceptCode":"C38218","definition":"Administration of a drug within the coronary arteries supplying blood to the tissues of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B0DA-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracorneal","valueDescription":"Intracorneal Route of Administration","ValueMeaning":{"publicId":"2578000","version":"1","preferredName":"Intracorneal Route of Administration","longName":"2578000","preferredDefinition":"Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracorneal Route of Administration","conceptCode":"C38234","definition":"Administration of a drug within the eye cornea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDBD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B0EF-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracisternal","valueDescription":"Intracisternal Route of Administration","ValueMeaning":{"publicId":"2578083","version":"1","preferredName":"Intracisternal Route of Administration","longName":"2578083","preferredDefinition":"Administration within the cisterna magna cerebellomedularis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracisternal Route of Administration","conceptCode":"C38233","definition":"Administration of a drug directly into the cerebrospinal fluid of the brain ventricles. It could be performed by direct injection into the cisterna magna or via permanently positioned tube.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FE10-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-03-01","modifiedBy":"ONEDATA","dateModified":"2006-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B104-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracerebral","valueDescription":"Intracerebral Route of Administration","ValueMeaning":{"publicId":"2577999","version":"1","preferredName":"Intracerebral Route of Administration","longName":"2577999","preferredDefinition":"Administration within the cerebrum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracerebral Route of Administration","conceptCode":"C38232","definition":"Administration of a drug within the cerebrum, directly into brain tissue, usually by injection or direct application.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDBC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B119-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracavernous","valueDescription":"Intracavernous Route of Administration","ValueMeaning":{"publicId":"2577933","version":"1","preferredName":"Intracavernous Route of Administration","longName":"2577933","preferredDefinition":"Administration of a drug within a pathologic cavity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracavernous Route of Administration","conceptCode":"C38230","definition":"Administration of a drug within a pathologic cavity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FD7A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-26","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-26","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B12E-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracardiac","valueDescription":"Intracardiac Route of Administration","ValueMeaning":{"publicId":"2577996","version":"1","preferredName":"Intracardiac Route of Administration","longName":"2577996","preferredDefinition":"Administration within the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracardiac Route of Administration","conceptCode":"C38227","definition":"Administration of a drug within the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B143-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intrauterine","valueDescription":"Intrauterine Route of Administration","ValueMeaning":{"publicId":"2577981","version":"1","preferredName":"Intrauterine Route of Administration","longName":"2577981","preferredDefinition":"Administration within the uterus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrauterine Route of Administration","conceptCode":"C38272","definition":"The administration of a drug within the uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B14E-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intraarterial","valueDescription":"Intraarterial Route of Administration","ValueMeaning":{"publicId":"2578037","version":"1","preferredName":"Intraarterial Route of Administration","longName":"2578037","preferredDefinition":"Administration within an artery or arteries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarterial Route of Administration","conceptCode":"C38222","definition":"The administration of a substance directly into an artery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDE2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B178-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intraamniotic","valueDescription":"Intraamniotic Route of Administration","ValueMeaning":{"publicId":"2577991","version":"1","preferredName":"Intraamniotic Route of Administration","longName":"2577991","preferredDefinition":"Administration within the amnion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraamniotic Route of Administration","conceptCode":"C38221","definition":"Administration of the drug within the amnion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B18D-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intraarticular","valueDescription":"Intraarticular Route of Administration","ValueMeaning":{"publicId":"2577992","version":"1","preferredName":"Intraarticular Route of Administration","longName":"2577992","preferredDefinition":"Administration within a joint.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intraarticular Route of Administration","conceptCode":"C38223","definition":"Administration of the drug within a joint.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B163-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Intracorporus Cavernosum","valueDescription":"Intracorporus Cavernosum Route of Administration","ValueMeaning":{"publicId":"2578002","version":"1","preferredName":"Intracorporus Cavernosum Route of Administration","longName":"2578002","preferredDefinition":"Administration within the dilatable spaces of the corporus cavernosa of the penis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracorporus Cavernosum Route of Administration","conceptCode":"C38235","definition":"Administration of a drug within the dilatable venous spaces of the cavernous tissue of the penis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDBF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B1A2-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Hemodialysis","valueDescription":"Administration Via Hemodialysis","ValueMeaning":{"publicId":"2577987","version":"1","preferredName":"Administration Via Hemodialysis","longName":"2577987","preferredDefinition":"Administration through hemodialysate fluid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administration via Hemodialysis","conceptCode":"C38200","definition":"Method of administering the drug through hemodialysate fluid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDB0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B1B7-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Extraamniotic","valueDescription":"Extraamniotic Route of Administration","ValueMeaning":{"publicId":"2577986","version":"1","preferredName":"Extraamniotic Route of Administration","longName":"2577986","preferredDefinition":"Administration to the outside of the membrane enveloping the fetus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extraamniotic Route of Administration","conceptCode":"C38211","definition":"Administration of the drug to the outside of the membrane enveloping the fetus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B1CC-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Epidural","valueDescription":"Epidural Route of Administration","ValueMeaning":{"publicId":"2577985","version":"1","preferredName":"Epidural Route of Administration","longName":"2577985","preferredDefinition":"Administration upon or over the dura mater.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epidural Route of Administration","conceptCode":"C38210","definition":"Administration of the drug in the epidural space, usually at the lumbar level of the spine. The drug must initially cross the dura mater before exerting its effect on the nervous system components. The drug is also subject to uptake into the rich epidural plexus of veins. Uptake and distribution after epidural administration resembles that seen after intramuscular injection. The portion of drug that is not taken into the vascular compartment is available to cross the dura. Hydrophilicity is a major component in the pharmacokinetics of drug transfer into the subdural space.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B1E1-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Endotracheal","valueDescription":"Endotracheal Route of Administration","ValueMeaning":{"publicId":"2577075","version":"1","preferredName":"Endotracheal Route of Administration","longName":"2577075","preferredDefinition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endotracheal Route of Administration","conceptCode":"C38208","definition":"Endotracheal drug administration involves the introduction of the agent directly through the endotracheal tube in an intubated patient. Generally this route is considered as a last resort for drug administration, and provides a fast, effective means of drug delivery in a patient who requires immediate medication. Plasma levels obtained via endotracheal administration are considerably less than those obtained with an equal dosage administered intravenously or intraosseously. Endotracheal administration must be followed by hyper-insufflation of the lungs to promote optimal drug absorption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA20-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B1F6-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Endosinusial","valueDescription":"Endosinusial Route of Administration","ValueMeaning":{"publicId":"2577984","version":"1","preferredName":"Endosinusial Route of Administration","longName":"2577984","preferredDefinition":"Administration within the nasal sinuses of the head.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endosinusial Route of Administration","conceptCode":"C38206","definition":"Administration of the drug within the nasal sinuses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDAD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B20B-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Endocervical","valueDescription":"Endocervical Route of Administration","ValueMeaning":{"publicId":"2577980","version":"1","preferredName":"Endocervical Route of Administration","longName":"2577980","preferredDefinition":"Administration within the canal of the cervix uteri. Synonymous with the term intracervical.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocervical Route of Administration","conceptCode":"C38205","definition":"Administration of the drug within the canal of the cervix uteri.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B220-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Dental","valueDescription":"Dental Route of Administration","ValueMeaning":{"publicId":"4632532","version":"1","preferredName":"Dental Route of Administration","longName":"4632532","preferredDefinition":"Administration of the drug to a tooth or teeth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dental Route of Administration","conceptCode":"C38197","definition":"Administration of the drug to a tooth or teeth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09F64D6B-B22B-B9CE-E050-BB89AD437D7C","latestVersionIndicator":"Yes","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B244-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Cutaneous","valueDescription":"Cutaneous Route of Administration","ValueMeaning":{"publicId":"2577979","version":"1","preferredName":"Cutaneous Route of Administration","longName":"2577979","preferredDefinition":"Administration to the skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Route of Administration","conceptCode":"C38675","definition":"Administration to the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B258-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Buccal","valueDescription":"Buccal Route of Administration","ValueMeaning":{"publicId":"2577975","version":"1","preferredName":"Buccal Route of Administration","longName":"2577975","preferredDefinition":"Administration directed toward the cheek, generally from within the mouth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Buccal Route of Administration","conceptCode":"C38193","definition":"Administration of a substance through the mucosal membrane on the inside of the cheek or the back of the mouth. Buccal route bypasses first pass metabolism and avoids pre-systemic elimination in the gastrointestinal tract. The buccal environment is well supplied with both vascular and lymphatic drainage and is well suited for a retentive device. This is a feasible alternative for systemic delivery of orally inefficient drugs, such as peptide and protein drug molecules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDA4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"FRAZIERP","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B26D-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"},{"value":"Auricular","valueDescription":"Auricular Route of Administration","ValueMeaning":{"publicId":"4632533","version":"1","preferredName":"Auricular Route of Administration","longName":"4632533","preferredDefinition":"Administration to or by way of the ear.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Auricular Route of Administration","conceptCode":"C38192","definition":"Administration of the drug to or by way of the ear. The drug action is mostly topical/local.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09F64D6B-B278-B9CE-E050-BB89AD437D7C","latestVersionIndicator":"Yes","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"09F64D6B-B291-B9CE-E050-BB89AD437D7C","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"ONEDATA","dateModified":"2014-12-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FDA:FDA MedWatch Form 3500","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09F64D6B-B025-B9CE-E050-BB89AD437D7C","latestVersionIndicator":"Yes","beginDate":"2014-12-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-11","modifiedBy":"HARTLEYG","dateModified":"2018-11-07","changeDescription":"Released as part of the Draft New Cleanup_11.07.18; FDA MedWatch Form 3500 route values","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4382692","version":"1","longName":"FDA MedWatch Form 3500","context":"ONC SDC Project","ClassificationSchemeItems":[{"publicId":"4394093","version":"1","longName":"Suspect Product(s)","context":"ONC SDC Project"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Route","type":"Preferred Question Text","description":"Route","url":null,"context":"ONC SDC Project"}],"origin":"FDA:FDA MedWatch Form 3500","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A42DC54-D6A2-6CA0-E050-BB89AD431B37","latestVersionIndicator":"Yes","beginDate":"2014-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-15","modifiedBy":"HARTLEYG","dateModified":"2018-11-07","changeDescription":"Released as part of the Draft New Cleanup_11.07.18; Curated to support FDA MedWatch Form 3500","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}